Research Letter

Journal of Human Hypertension (2008) 22, 512–515; doi:10.1038/jhh.2008.23; published online 17 April 2008

The protective effect of KCNMB1 E65K against hypertension is restricted to blood pressure treatment with bold beta-blockade

A Kelley-Hedgepeth1, I Peter2, K E Kip3, M C Montefusco1, S Kogan1, D Cox1, J M Ordovas4, D Levy5,6, S E Reis7, M E Mendelsohn1, D Housman8 and G S Huggins1

  1. 1MCRI Center for Translational Genomics, Molecular Cardiology Research Institute, Tufts Medical Center, Boston, MA, USA
  2. 2Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA, USA
  3. 3University of South Florida, Tampa, FL, USA
  4. 4Jean Mayer-USDA Human Nutrition Research Center, Tufts University, Boston, MA, USA
  5. 5NHLBI Framingham Heart Study, Framingham, MA, USA
  6. 6Center for Population Studies, National Heart, Lung and Blood Institute, Bethesda, MD, USA
  7. 7University of Pittsburgh, Pittsburgh, PA, USA
  8. 8Massachusetts Institute of Technology, Cambridge, MA, USA

Correspondence: GS Huggins, E-mail: ghuggins@tufts-nemc.org

Top

MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated

NEWS AND VIEWS

Salt wasting and blood pressure

Nature Genetics News and Views (01 May 2008)

Extra navigation

.

naturejobs

natureproducts


ADVERTISEMENT